CD8 T cell and B cell collaboration following subunit vaccination
CD8 T cell and B cell collaboration following subunit vaccination
批准号:
10055979
负责人:
Ross M Kedl
金额:
$52.42万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-19 至 2024-07-31
关键词:
AdjuvantAgonistAnimal ModelAntibodiesAntibody FormationAntibody ResponseAntigen PresentationAntigen-Presenting CellsAntigensAttenuatedAutomobile DrivingB-Cell ActivationB-LymphocytesBiologyCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD80 geneCD8B1 geneCXCR3 geneCell SurvivalCellsCellular ImmunityClinicalCollaborationsCross PresentationDataDendritic cell activationDevelopmentDissectionFDA approvedFormulationGenerationsHIVHerpesvirus 1HumorHumoral ImmunitiesImmune responseImmune systemImmunityImmunizationImmunologic MemoryImmunologicsInfectionInfectious AgentInterleukin-15Listeria monocytogenesLymphocyte BiologyLymphocytic choriomeningitis virusMaintenanceMalariaMalignant NeoplasmsMeaslesMemoryMetabolicModelingMumpsMusNatural ImmunityNatureOX40Pathway interactionsPattern recognition receptorPositioning AttributePreventive vaccinePrimatesProcessProductionProtein SubunitsPublishingRegulationRoleRubellaSignal TransductionSmallpox VirusesSubunit VaccinesT cell responseT memory cellT-LymphocyteTNFRSF5 geneTNFSF5 geneTestingTuberculosisVaccinationVaccine AdjuvantVaccine DesignVaccinesVaccinia virusViralViral Vectorcell motilityclinically relevantcytokinecytotoxic CD8 T cellsdefined contributioneffector T cellexperiencemouse modelnonhuman primatenovelparticlepathogenprogramsresponsesuccesstherapeutic vaccinetranscription factorvaccination strategyvaccine candidatevaccine developmentvaccine response
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Some of the most successful vaccines to date, including those against the deadly viruses small pox, measles,
mumps, and rubella, comprise attenuated viral particles, capable of inducing both humoral and cellular
immunity. However, because protection through live infection is not feasible for many pathogens, including
HIV, malaria, tuberculosis, and cancer, alternative vaccine approaches are needed. A single immunization
with a protein subunit antigen and a combination of agonists toward pattern recognition receptors and CD40
(combined-adjuvant subunit vaccine) generates a magnitude of CD8+ and CD4+ T cell responses that is
exponentially larger than those typically induced by viral vectors in both mice and non-human primates. Given
the clinical promise of this vaccine platform, the careful study of the mechanisms controlling its potency may
uncover novel targets for the development of more effective prophylactic and therapeutic vaccines.
Over the past decade, studies of immunization and infection have revealed shared and distinct pathways
utilized in the generation of immunological memory. We have documented a unique metabolic program used
by expanding vaccine-elicited T cells, and requirements for cytokines (IL-15, IL-27) and transcription factors
(Tbet, Eomes) that are dispensable for the expansion of infection-elicited T cells. These discrepancies led us to
question other factors previously thought to be unimportant for the generation of CD8+ T cell responses, such
as the concurrent activation and proliferation of antigen-specific B cells. Given the disproportionate expansion
of B cells very early following subunit immunization, it seemed plausible that B cells could provide
costimulatory support for the ensuing CD8+ T cell response, either directly, or indirectly. Preliminary data
support this unconventional proposition. In fact, preliminary data also show that CD8+ T cell responses
likewise benefit the antibody response to subunit vaccination.
We do not yet understand the underlying mechanisms that integrate B cells and CD8+ T cells for the
generation of long-lived cellular and humoral immunity. Our proposal will use classic immunological
approaches to fully elucidate, specific to the context of subunit vaccination, 1) the role of B cell antigen
presentation and cytokine production in the regulation of CD8+ T cell survival and cell fate determination, 2) the
role of B cells in CD8+ T cell memory formation and maintenance, and 3) the mechanisms by which antigen-
specific CD8+ T cells influence B cell activation and antibody formation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
mRNA encoding of immune receptor-targeting antibodies for the augmentation of vaccine-elicited cellular immunity.
-
批准号:10508093
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2022
-
负责人:Ross M Kedl
-
依托单位:
mRNA encoding of immune receptor-targeting antibodies for the augmentation of vaccine-elicited cellular immunity.
-
批准号:10662571
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2022
-
负责人:Ross M Kedl
-
依托单位:
Exploring the heterogeneity of the vaccine-elicited T cell response by scRNAseq
-
批准号:10334559
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2021
-
负责人:Ross M Kedl
-
依托单位:
Exploring the heterogeneity of the vaccine-elicited T cell response by scRNAseq
-
批准号:10218805
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2021
-
负责人:Ross M Kedl
-
依托单位:
CD8 T cell and B cell collaboration following subunit vaccination
-
批准号:10450847
-
项目类别:
-
资助金额:$48.57万
-
财政年份:2020
-
负责人:Ross M Kedl
-
依托单位:
CD8 T cell and B cell collaboration following subunit vaccination
-
批准号:10662244
-
项目类别:
-
资助金额:$47.76万
-
财政年份:2020
-
负责人:Ross M Kedl
-
依托单位:
CD8 T cell and B cell collaboration following subunit vaccination
-
批准号:10242218
-
项目类别:
-
资助金额:$49.37万
-
财政年份:2020
-
负责人:Ross M Kedl
-
依托单位:
Molecular and cellular basis of Combined Adjuvant-Elicited Cellular Immunity
-
批准号:9312770
-
项目类别:
-
资助金额:$50.05万
-
财政年份:2016
-
负责人:Ross M Kedl
-
依托单位:
Molecular and cellular basis of Combined Adjuvant-Elicited Cellular Immunity
-
批准号:9197094
-
项目类别:
-
资助金额:$52.02万
-
财政年份:2016
-
负责人:Ross M Kedl
-
依托单位:
Lymphatic endothelial cell capture and maintenance of antigen
-
批准号:8895716
-
项目类别:
-
资助金额:$38.2万
-
财政年份:2015
-
负责人:Ross M Kedl
-
依托单位:
Virtual Memory T Cell Development and Responses In Vivo
-
批准号:9023407
-
项目类别:
-
资助金额:$35.02万
-
财政年份:2013
-
负责人:Ross M Kedl
-
依托单位:
Virtual Memory T Cell Development and Responses In Vivo
-
批准号:9222698
-
项目类别:
-
资助金额:$35.02万
-
财政年份:2013
-
负责人:Ross M Kedl
-
依托单位:
Virtual Memory T Cell Development and Responses In Vivo
-
批准号:8436534
-
项目类别:
-
资助金额:$35.6万
-
财政年份:2013
-
负责人:Ross M Kedl
-
依托单位:
Virtual Memory T Cell Development and Responses In Vivo
-
批准号:8634018
-
项目类别:
-
资助金额:$35.31万
-
财政年份:2013
-
负责人:Ross M Kedl
-
依托单位:
Antigen Persistence and Protective Immunity After Protein Vaccination
-
批准号:8502418
-
项目类别:
-
资助金额:$18.62万
-
财政年份:2012
-
负责人:Ross M Kedl
-
依托单位:
Antigen Persistence and Protective Immunity After Protein Vaccination
-
批准号:8386477
-
项目类别:
-
资助金额:$24.08万
-
财政年份:2012
-
负责人:Ross M Kedl
-
依托单位:
Combined TLR/CD40-Agonist Induced CD8+ T Cell Memory
-
批准号:8305322
-
项目类别:
-
资助金额:$38.68万
-
财政年份:2011
-
负责人:Ross M Kedl
-
依托单位:
Transcriptional regulation of vaccine-elicited and infection-elicited CD8+ T cell responses
-
批准号:10083688
-
项目类别:
-
资助金额:$38.88万
-
财政年份:2007
-
负责人:Ross M Kedl
-
依托单位:
IFNalphaBeta-Dependent and-Independent TLR/CD40 Synergy
-
批准号:7745527
-
项目类别:
-
资助金额:$37.39万
-
财政年份:2007
-
负责人:Ross M Kedl
-
依托单位:
IL-27 in Vaccine-Elicited Cellular Immunity
-
批准号:8586517
-
项目类别:
-
资助金额:$38.1万
-
财政年份:2007
-
负责人:Ross M Kedl
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: